Biotech & Biological Manufacturing
Advanced Cell Manufacturing, GMP Infrastructure & Bioprocessing Solutions
Future Health GCC provides advanced laboratory infrastructure, technical expertise and bioprocessing support for biotechnology companies, hospitals, research institutions, regenerative medicine programs and cell therapy developers.
About Future Health GCC Biotech
Future Health GCC supports the development, processing, preservation and manufacturing needs of organizations working across biotechnology and cell-based applications. Through our laboratory infrastructure in Dubai, our team can provide tailored technical support across cell processing, biobanking, cryogenic storage, quality-control coordination and project-specific manufacturing workflows.
Our model is designed to give partners access to specialized infrastructure and technical expertise without the need to build and operate a complete in-house cell-processing facility.
Our Services
Comprehensive solutions designed to support innovation, quality, operational efficiency and the advancement of biotechnology and cell-based projects.
GMP Infrastructure Access
Access to suitable controlled processing areas, cleanroom infrastructure, laboratory equipment and cryogenic capabilities for approved biotechnology and cell-processing activities. Flexible access models may be developed according to project requirements and facility availability.
Contract Cell Manufacturing
Project-based cell processing and manufacturing support that may include MSC isolation and expansion, adipose-derived cell processing, PBMC processing, CD34+ processing, cord blood processing and master cell bank development, subject to approved project scope and applicable regulatory requirements.
Biobanking & Cryostorage
Long-term cryopreservation and monitored storage solutions for eligible stem cells, cord blood, cellular materials, biological tissues and master cell banks, supported by controlled storage systems and documented traceability.
Analytical & Quality Control Support
Quality-control and analytical testing support may include, depending on project requirements and available validated methods, sterility, endotoxin, mycoplasma, viability, cell count, flow cytometry, CD34+ enumeration and other project-specific testing. Testing performed through external qualified partners should be clearly identified where applicable.
Your Biotech Project Journey with Future Health GCC
Initial Consultation
We begin by understanding the project scope, intended application, facility requirements, processing or manufacturing objectives and anticipated regulatory pathway.
Technical Assessment
Our team reviews the proposed process, equipment requirements, cleanroom needs, quality-control requirements, documentation expectations and operational feasibility.
Proposal & Project Plan
A tailored project scope is developed outlining the proposed services, timeline, facility requirements, technical deliverables and commercial structure.
Onboarding & Documentation
The project is formally onboarded with the required quality agreements, SOP alignment, batch documentation, training requirements, access arrangements and relevant compliance documentation.
Execution
The approved scope is carried out, which may include facility access, cell processing, manufacturing support, quality-control activities, cryopreservation, storage or technical consulting.
Reporting & Handover
At completion, the applicable project documentation is compiled, which may include batch records, QC results, storage records, processing summaries and agreed technical deliverables.
GMP Infrastructure
Infrastructure Designed to Support Advanced Cell Processing
Future Health GCC’s laboratory infrastructure supports controlled cell-processing and biological preservation workflows, with quality systems, monitored environments and specialist processing capabilities designed around the requirements of advanced biotechnology projects.
- GMP-Controlled Cleanroom Environment
- Controlled Processing Areas
- Advanced Cell-Processing Suites
- Quality-Control Support
- Cryogenic Storage Infrastructure
- Controlled Workflow Design
- Environmental Monitoring
- Sample Identification & Traceability
Industries We Support
- Biotechnology Companies & Startups
- Cell Therapy Developers
- Hospitals & Clinics
- Regenerative Medicine Programs
- Pharmaceutical & Life Science Companies
- Universities
- Research Institutions
- Healthcare Innovation Partners
Flexible Service Models
Infrastructure Access Model
Flexible access to eligible laboratory and controlled processing infrastructure based on the approved project scope, duration and operational requirements.
Manufacturing Model
Contract cell-processing and manufacturing support covering agreed processing steps, documentation, quality-control support, cryopreservation and batch-related activities.
Partnership Model
Long-term partnerships for biobanking, cryostorage, research support, manufacturing programs, hospital collaborations or white-label service models, subject to technical and regulatory feasibility.
Frequently Asked Questions
Who can work with Future Health GCC on biotech and manufacturing projects?
We can assess projects from biotechnology companies, healthcare organizations, hospitals, clinics, research institutions, universities and other qualified partners requiring specialist cell-processing, biobanking or laboratory support.
What types of cell processing can Future Health GCC support?
Depending on the approved project scope and regulatory requirements, capabilities may include cord blood processing, CD34+ processing, MSC isolation and culture, adipose-derived cell processing, PBMC-related processing, cryopreservation and master cell bank development. The exact scope should be confirmed during technical assessment.
What information is required to assess a project?
Typical information may include the organization profile, project overview, intended use, proposed process, sample or cell type, study protocol where applicable, expected volumes, required deliverables, quality requirements and relevant regulatory pathway.
Can Future Health GCC support both research and clinical-development projects?
Projects can be assessed individually based on their intended use, technical requirements, facility scope and applicable regulatory approvals. The final service scope should clearly define whether materials are intended for research, development or another authorized use.
Is cryogenic storage available after processing or manufacturing?
Future Health GCC can assess long-term cryogenic storage requirements for eligible cells, tissues and biological materials as part of the project scope.
Can organizations without their own cell-processing laboratory work with Future Health GCC?
Yes. One of the objectives of the service model is to give qualified partners access to specialist infrastructure and technical capabilities without requiring them to establish a complete in-house facility, subject to project assessment and approval.
Start Your Biotech Project with Future Health GCC
Whether you require advanced cell processing, biological manufacturing support, cryogenic storage, laboratory infrastructure or a long-term technical partnership, our team can assess your requirements and develop a tailored project approach.
Request a Proposal
Share your project requirements and receive a tailored technical and commercial proposal.
Book a Technical Consultation
Meet with our team to discuss your project scope, technical requirements and potential service pathway.
Request a Facility Tour
Visit our Dubai facility and explore the infrastructure and capabilities relevant to your project.
Partner with Future Health GCC
Discuss long-term manufacturing, biobanking, research, hospital or white-label collaboration opportunities.